[go: up one dir, main page]

WO2004047799A3 - Pellets containing non-aqueous fluids and the process for their preparation - Google Patents

Pellets containing non-aqueous fluids and the process for their preparation Download PDF

Info

Publication number
WO2004047799A3
WO2004047799A3 PCT/SI2003/000042 SI0300042W WO2004047799A3 WO 2004047799 A3 WO2004047799 A3 WO 2004047799A3 SI 0300042 W SI0300042 W SI 0300042W WO 2004047799 A3 WO2004047799 A3 WO 2004047799A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
containing non
aqueous fluids
pellets containing
polyhydroxy alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SI2003/000042
Other languages
French (fr)
Other versions
WO2004047799A2 (en
Inventor
Judita Sirca
Stanko Srcic
Rok Dreu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Priority to AU2003302380A priority Critical patent/AU2003302380A1/en
Publication of WO2004047799A2 publication Critical patent/WO2004047799A2/en
Publication of WO2004047799A3 publication Critical patent/WO2004047799A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pellets characterized in that an agglomerating fluid used for their preparation is liquid polyhydroxy alcohol which may be in a mixture with water or another pharmaceutically acceptable solvent which is more easily volatile than said polyhydroxy alcohol and further characterized in that said agglomerating fluid completely or partly remains in a finished pharmaceutical dosage form.
PCT/SI2003/000042 2002-11-27 2003-11-25 Pellets containing non-aqueous fluids and the process for their preparation Ceased WO2004047799A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003302380A AU2003302380A1 (en) 2002-11-27 2003-11-25 Pellets containing non-aqueous fluids and the process for their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200286A SI21353A (en) 2002-11-27 2002-11-27 Pellet-containing anhydrous liquids and process of their preparation
SIP200200286 2002-11-27

Publications (2)

Publication Number Publication Date
WO2004047799A2 WO2004047799A2 (en) 2004-06-10
WO2004047799A3 true WO2004047799A3 (en) 2004-09-10

Family

ID=32391127

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SI2003/000042 Ceased WO2004047799A2 (en) 2002-11-27 2003-11-25 Pellets containing non-aqueous fluids and the process for their preparation

Country Status (3)

Country Link
AU (1) AU2003302380A1 (en)
SI (1) SI21353A (en)
WO (1) WO2004047799A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090130208A1 (en) * 2007-11-21 2009-05-21 Capricorn Pharma Inc. Modified release niacin formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290990B1 (en) * 1994-04-18 2001-09-18 Basf Aktiengesellschaft Slow-release matrix pellets and the production thereof
US20020123503A1 (en) * 2000-12-21 2002-09-05 Malcolm Ross Cabergoline pharmaceutical compositions and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290990B1 (en) * 1994-04-18 2001-09-18 Basf Aktiengesellschaft Slow-release matrix pellets and the production thereof
US20020123503A1 (en) * 2000-12-21 2002-09-05 Malcolm Ross Cabergoline pharmaceutical compositions and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 15 May 2002 (2002-05-15), BOUTELL S ET AL: "The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization", XP002283561, Database accession no. PREV200200362166 *
INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON), vol. 238, no. 1-2, 15 May 2002 (2002-05-15), pages 61 - 76, ISSN: 0378-5173 *
LWA M F L ET AL: "EFFECT OF COMMON CLASSES OF EXCIPIENTS ON EXTRUSION-SPHERONIZATION", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS INC. LONDON, GB, vol. 14, no. 5, 1 September 1997 (1997-09-01), pages 647 - 657, XP000659520, ISSN: 0265-2048 *

Also Published As

Publication number Publication date
AU2003302380A8 (en) 2004-06-18
WO2004047799A2 (en) 2004-06-10
SI21353A (en) 2004-06-30
AU2003302380A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
WO2005048923A3 (en) Extended release venlafaxine formulation
NO982161L (en) Administration media for analgesic, anti-inflammatory and antipyretic drugs containing nitric oxide and pharmaceutical compositions containing such media and drugs
AU2003231071A1 (en) Low viscosity liquid dosage forms
EP1550687A4 (en) Novel organopolysiloxane polymer, pasty composition, and cosmetic preparation containing the composition
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
NO20071315L (en) Pharmaceutical preparation in the form of a tablet containing an active principle for abdominal distention.
WO2004066939A3 (en) Controlled-release drug delivery system
WO2006021160A8 (en) Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
AR045094A1 (en) LCIFILIZED FORMULATIONS OF CCI-779
WO2008069938A3 (en) Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
WO2007050294A3 (en) Liquid dosage forms having enteric properties of delayed and then sustained release
MXPA04011990A (en) Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same.
WO2004047799A3 (en) Pellets containing non-aqueous fluids and the process for their preparation
DE60123084D1 (en) Flexible container for use in a liquid dispenser
AU2003252527A1 (en) Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection
WO2005076829A3 (en) Stable loratadine spill resistant formulation
WO2008005287A8 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
EP0920860A3 (en) Slow-release high-viscous liquid composition for a volatile substance
UA80872C2 (en) Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
WO2006053882A3 (en) Benzothiazole formulations and use thereof
WO2004050714A3 (en) Insoluble, highly cross-linked popcorn polymers containing styrene-4-sulfonate, methods for the production and use thereof
WO2006023295A3 (en) Pharmaceutical compositions comprising effervescent agents and fenofibrate
MXPA05012297A (en) Indazole having analgesic activity ,.
WO2006094736A3 (en) Alfuzosin controlled-release formulations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP